AOD-9604 Regulatory Status As of June 2026, AOD-9604 is not FDA-approved for any therapeutic use
Tablets just as effective Over-the-counter B12 tablets are a fraction of the cost of shots, and have been shown in a British-Canadian study to work just as well for most people, although some people with digestive conditions may have difficulty absorbing the vitamin in tablet form
Its formulation is intended for subcutaneous injection
An average body weight reduction of 15% over 104 weeks , underscoring its effectiveness in sustainable weight management, as studied by Kadowaki T et al
Semaglutide reduces how much you spend, allowing withdrawals to start
While it is not a direct treatment for mental health conditions, some studies suggest that stabilizing blood sugar and reducing inflammation might also improve mood